• No results found

diffuse large B-cell lymphoma patients

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab

... ADCC-induced lymphoma cell lysis, were found to relate to the clinical response of rituximab ...of lymphoma cells by the inhibition of STAT3 ...DLBCL patients with homozygous genotypes in ...

6

Rituximab Improves Overall Survival in Patients Treated with CODOX M/IVAC for Burkitt Lymphoma (BL) and B Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B Cell Lymphoma and BL (BCL U): A Single Center Experience and Review

Rituximab Improves Overall Survival in Patients Treated with CODOX M/IVAC for Burkitt Lymphoma (BL) and B Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B Cell Lymphoma and BL (BCL U): A Single Center Experience and Review of the Literature

... tients were initially misclassified as DLBCL and treated with chemotherapy other than CODOX-M for cycle # 1 (mostly R-CHOP). Starting with “less-intense chemotherapy” did not seem to negatively impact clinical out- ...

12

IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt’s lymphoma

IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt’s lymphoma

... magnification, each case demonstrated a diffuse growth pattern with complete effacement of normal lymphoid architecture. Each case also showed a high mitotic rate and a “ starry sky ” pattern. At higher power ...

6

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future

... Abstract: Diffuse large B-cell lymphoma (DLBCL) is the most commonly occurring lymphoma in the Western ...all patients with DLBCL and can cure the disease in certain ...

12

The role of HGF/c-MET signaling pathway in lymphoma

The role of HGF/c-MET signaling pathway in lymphoma

... increased cell proliferation, survival, mi- gration/invasion, angiogenesis, and metastasis in can- cer cells ...non-small cell lung cancer (NSCLC) patients [8, 12, ...in lymphoma, a group of ...

8

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma

... targeting B cell pathways such as bortezomib or pomalidomide [9, ...all patients received local therapy of either intravit- real methotrexate, rituximab, or ...Most patients also received ...

5

DIFFUSE LARGE B CELL LYMPHOMA OF THE HEART: A CASE REPORT

DIFFUSE LARGE B CELL LYMPHOMA OF THE HEART: A CASE REPORT

... malignant lymphoma represents uncommon ...of patients with end stage malignant ...those patients since the difficulty of carrying out a surgical biopsy, which generally cannot be achieved because of ...

5

The Impact of Human Immunodeficiency Virus Infection (HIV) on Lymphoma in South Africa

The Impact of Human Immunodeficiency Virus Infection (HIV) on Lymphoma in South Africa

... NHL patients at Chris Hani Baragwanath Academic Hospital (CHBAH), Soweto, Johannesburg, are HIV ...as B- cell, high grade lymphomas, including diffuse large B-cell ...

9

Diffuse Large B Cell Lymphoma: A Single Centre Study.

Diffuse Large B Cell Lymphoma: A Single Centre Study.

... for patients with DLBCL, relapse remains a consistent clinical ...many patients have been salvaged at relapse with ASCT in the past, 41,42,43 current DLBCL patients are at higher risk when they ...

87

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

... many cell lines it appears that response to BCL6 inhibitors correlates with BCL6 levels, in that higher doses are required to suppress cell lines that express more ...firming cell line data showing ...

13

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent

... following lymphoma response and the absence of multiple myeloma features suggest that the paraprotein was produced by the lymphoma ...center B-cells and is associated with an up-regulation of ...

6

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma

... risk-benefit assessment that was performed by the inde- pendent Data and Safety Monitoring Board (DSMB) on 30 May 2010. There were several articles discussed the bevacizumab treatment in NHL before, but none of them ...

5

Spectrum of imaging findings in AIDS-related diffuse large B cell lymphoma

Spectrum of imaging findings in AIDS-related diffuse large B cell lymphoma

... of diffuse large B cell lymphoma is usually a manifestation of systemic disease rather than primary pulmonary lymphoma ...pulmonary lymphoma in the setting of HIV have ...

8

Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma

Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma

... ABC: B cell activated or non-germinal centre; B-CLU/DLBCL/LB: B-cell lymphoma unclassifiable, with features intermediate between diffuse large B-cell ...

9

Diffuse large B cell lymphoma with central pontine myelinolysis

Diffuse large B cell lymphoma with central pontine myelinolysis

... neuronal cell membrane ...in patients with large B-cell lymphoma ...articles, large B cell lymphoma with pontine involvement was described [11, ...

5

Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities

Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities

... of large B-cell lymph- oma in the revised WHO classification of 2016, it has been reported to have unique clinicopathologic features and very poor outcomes with frequent relapse [2, 4, 5, ...DLBCL ...

6

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma

... 35 patients with A-DLBCL, we defined A-DLBCL based on morphology and recog- nized the distinctiveness of this neoplasm from ordinary DLBCLs in terms of genetic alterations and biologic fea- tures, which contained ...

8

Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein Barr virus associated lymphoma

Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein Barr virus associated lymphoma

... of lymphoma and cancer. According to a recent classification of lymphoma, EBV is associated with cer- tain cases of Burkitt lymphoma, diffuse large-B-cell lymphoma ...

5

Original Article Clinicopathological characteristics and prognostic analysis of Epstein-Barr virus-positive lymphoma: a meta-analysis

Original Article Clinicopathological characteristics and prognostic analysis of Epstein-Barr virus-positive lymphoma: a meta-analysis

... in patients with ...associated lymphoma, EBV positive lymphoma, EBV related lymphoma and ...of lymphoma patients by hazard ratios (HRs) with 95% confidence intervals (95% ...784 ...

10

Natural course of diffuse large B cell lymphoma—a manifestation in buccal mucosa

Natural course of diffuse large B cell lymphoma—a manifestation in buccal mucosa

... Non-Hodgkin’s lymphoma of B cell lineage is the third most common malignant lesion in the oral cavity and maxillofacial ...Non-immunosuppressed patients of any age can be affected, most ...

5

Show all 10000 documents...

Related subjects